Advantages of the Molecular Structure of Aflibercept

PHOTON Results and Their Relation to DME Patients in Your Practice

The companies will focus their joint effort on extended-release therapies for ocular disease

New microbial strain produces high yields of lutein for AMD, cataract prevention

John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.

A row of beakers with yellow and orange fluid in a laboratory. Concept image for microbial lutein production, bioengineering, sustainable synthesis for cataract cornea age-related macular degeneration (AMD) and retinal disease. Image credit: bidala – stock.adobe.com

PULSAR Results and Their Relation to nAMD Patients in Your Practice

Researchers at the Korea Advanced Institute of Science and Technology demonstrated the next-generation strategy for sustainable synthesis

Precautionary class 2 medicines recall of Zaditen 0.25 mg/ml, eye drops, solution, issued

John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.

Patients with high genetic risk of AMD should avoid instant coffee, investigators say

A precautionary recall of Zaditen eye drops is issued due to potential microbial contamination, affecting batch 4V64. No adverse events reported.

A person sits at their laptop with a cup of coffee visible in the foreground. Concept image for instant coffee, AMD, age related macular degeneration, ocular health and instant coffee investigation. Image credit: ©Ljustina – stock.adobe.com

Re-Vana Therapeutics and Boehringer Ingelheim announce collaboration, licensing partnership

Investigators obtained data from genome‐wide association studies to examine the effects of instant coffee consumption

Related Content

PHOTON Results and Their Relation to DME Patients in Your Practice

The companies will focus their joint effort on extended-release therapies for ocular disease

New microbial strain produces high yields of lutein for AMD, cataract prevention

John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.

PULSAR Results and Their Relation to nAMD Patients in Your Practice

Researchers at the Korea Advanced Institute of Science and Technology demonstrated the next-generation strategy for sustainable synthesis

Precautionary class 2 medicines recall of Zaditen 0.25 mg/ml, eye drops, solution, issued

John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.

Patients with high genetic risk of AMD should avoid instant coffee, investigators say

A precautionary recall of Zaditen eye drops is issued due to potential microbial contamination, affecting batch 4V64. No adverse events reported.